Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Statin Use in COVID-19 Hospitalized Patients and Outcomes: A Retrospective Study
Hamideh Kouhpeikar, Hamidreza Khosaravizade Tabasi, Zahra Khazir, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

A Dual Pharmacological Strategy against COVID-19: The Therapeutic Potential of Metformin and Atorvastatin
Luis Adrián De Jesús‐González, Rosa M. del Ángel, Selvin Noé Palacios-Rápalo, et al.
Microorganisms (2024) Vol. 12, Iss. 2, pp. 383-383
Open Access | Times Cited: 5
Lipid-targeting antiviral strategies: current state and future perspectives
Ana-Belén Blázquez, Patricia Mingo‐Casas, Ernesto Quesada, et al.
Antiviral Research (2025), pp. 106103-106103
Closed Access
Statin-Associated Liver Dysfunction and Muscle Injury: epidemiology, Mechanisms, and Management Strategies
Mingming Ma, Yaoyao Xu, Sun Li-hua, et al.
International Journal of General Medicine (2024) Vol. Volume 17, pp. 2055-2063
Open Access | Times Cited: 4
Systematic Review and Meta-Analysis of Statin Use and Mortality, Intensive Care Unit Admission and Requirement for Mechanical Ventilation in COVID-19 Patients
Ut-Sam Lao, Chak-Fun Law, Daniel T. Baptista‐Hon, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 18, pp. 5454-5454
Open Access | Times Cited: 19
Role of Cytochrome P450 2C9 in COVID-19 Treatment: Current Status and Future Directions
Sharoen Yu Ming Lim, Basel Al Bishtawi, Willone Lim
European Journal of Drug Metabolism and Pharmacokinetics (2023) Vol. 48, Iss. 3, pp. 221-240
Open Access | Times Cited: 10
Pathogenic mechanisms of cardiovascular damage in COVID-19
Honghua Shao, Rui‐Xing Yin
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 3
Perturbed Lipid Metabolism Transduction Pathways in SARS-CoV-2 Infection and Their Possible Treating Nutraceuticals
Amrita Shukla, Ankita Singh, Smriti Tripathi
Journal of the American Nutrition Association (2024) Vol. 43, Iss. 7, pp. 614-626
Closed Access | Times Cited: 2
The role of platelets, neutrophils and endothelium in COVID-19 infection
Emanuela Falcinelli, Eleonora Petito, Paolo Gresele
Expert Review of Hematology (2022) Vol. 15, Iss. 8, pp. 727-745
Closed Access | Times Cited: 12
The impact of statin therapy on in‐hospital prognosis and endothelial function of patients at high‐to‐very high cardiovascular risk admitted for COVID‐19
Vanessa Bianconi, Massimo R. Mannarino, Elena Cosentini, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Closed Access | Times Cited: 7
Real-world evidence with a retrospective cohort of 15,968 COVID-19 hospitalized patients suggests 21 new effective treatments
Carlos Loucera, Rosario Carmona, Marina Esteban‐Medina, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 7
Distinct Features of Vascular Diseases in COVID-19
Alexandr Ceasovschih, Victorița Șorodoc, Annabelle Shor, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 2783-2800
Open Access | Times Cited: 6
Statin Use in Relation to COVID-19 and Other Respiratory Infections: Muscle and Other Considerations
Beatrice A. Golomb, Junhee Han, Peter H. Langsjoen, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 14, pp. 4659-4659
Open Access | Times Cited: 6
Repurposing of Chemotherapeutics to Combat COVID-19
Sisir Nandi, Bhabani Shankar Nayak, Mayank Kumar Khede, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 32, pp. 2660-2694
Closed Access | Times Cited: 10
The most important variables associated with death due to COVID‐19 disease, based on three data mining models Decision Tree, AdaBoost, and Support Vector Machine: A cross‐sectional study
Bita Shokri gharehhasani, Mansour Rezaei, Armin Naghipour, et al.
Health Science Reports (2024) Vol. 7, Iss. 7
Open Access | Times Cited: 1
Impact of Statin or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker on In-Hospital Mortality of COVID-19 Patients
Mohsen Gholinataj Jelodar, Samaneh Mirzaei, Majid Haji Maghsoudi
Journal of Pharmaceutical Care (2024)
Open Access | Times Cited: 1
Association of early statin initiation during COVID-19 admission with inpatient mortality at an academic health system in Illinois, March 2020 to September 2022: a target trial emulation using observational data
Adovich S. Rivera, Omar Al-Heeti, Matthew J. Feinstein, et al.
BMJ Open (2024) Vol. 14, Iss. 10, pp. e085547-e085547
Open Access | Times Cited: 1
COVID-19 and the heart
Αndrew Xanthopoulos, Angeliki Bourazana, Grigorios Giamouzis, et al.
World Journal of Clinical Cases (2022) Vol. 10, Iss. 28, pp. 9970-9984
Open Access | Times Cited: 8
Repurposing cholesterol lowering drugs in the treatment and management of monkeypox
Saravanan Sekaran, Suresh Kumar R Sekar
International Journal of Surgery (2023) Vol. 109, Iss. 1, pp. 60-61
Open Access | Times Cited: 4
Treating COVID-19: Targeting the Host Response, Not the Virus
David S. Fedson
Life (2023) Vol. 13, Iss. 3, pp. 712-712
Open Access | Times Cited: 4
Correlations between preoperative statin treatment with short- and long-term survival following colorectal cancer surgery: a propensity score-matched national cohort study
Lea Löffler, Ismail Gögenür, Mikail Gögenur
International Journal of Colorectal Disease (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 1
Hypercapnia increases ACE2 expression and pseudo-SARS-CoV-2 entry in bronchial epithelial cells by augmenting cellular cholesterol
Fei Chen, Aiko Matsuda, G. R. Scott Budinger, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Effects of statins on clinical outcomes in hospitalized patients with COVID-19
Paulo Ricardo Martins‐Filho, José Augusto Soares Barreto-Filho, Antônio Carlos Sobral Sousa
European Journal of Internal Medicine (2022) Vol. 104, pp. 113-115
Open Access | Times Cited: 5
Thyroid-Stimulating Hormone Predicts Total Cholesterol and Low-Density Lipoprotein Cholesterol Reduction during the Acute Phase of COVID-19
Massimo R. Mannarino, Vanessa Bianconi, Elena Cosentini, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 12, pp. 3347-3347
Open Access | Times Cited: 4
Statin use and clinical outcomes in hospitalized COVID-19 patients
Khalid Saud Alshaalan, Rahaf F. Alkahtani, Renad Althobaiti, et al.
Saudi Medical Journal (2024) Vol. 45, Iss. 2, pp. 171-178
Open Access
Correlations between pre-operative statin-treatment with short- and long-term survival following colorectal cancer surgery: A propensity score-matched national cohort study
Lea Löffler, Ismail Gögenür, Mikail Gögenur
Research Square (Research Square) (2024)
Open Access
Page 1 - Next Page

Scroll to top